Oncology Pipeline Analytics

$2,850.00

By combining data on the oncology drug delivery landscape with the relational power of analytics we’ve created a unique information resource that provides insight and clarity to market sector activity and competitive positioning within the oncology therapeutics space. By grouping and formatting information into visualizations that are easy to digest, readers gain a new and revealing perspective on the oncology drug development market.

Category:

Description

As immunotherapeutics in general – and immuno-oncology in particular – move to the forefront, the major oncology drug developers are beginning to align with specific therapeutic approaches, such as PARP and PD-1/PD-L1. Our analytics analysis of current active oncology trial data reveals these factors and how they are affecting the oncology drug development landscape. By combining data on the oncology drug delivery landscape with the relational power of analytics we’ve created a unique information resource that provides insight and clarity to market sector activity and competitive positioning within the oncology therapeutics space.